Showing results (221-230 of 232) with videos related to
Sort By:
Pageof 24
Lancet (London, England)|February 22, 1997
Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's diseaseW A Stack, S D Mann, A J Roy, et al.Alimentary Pharmacology & Therapeutics|January 29, 2000
Ibuprofen versus other non-steroidal anti-inflammatory drugs: use in general practice and patient perceptionJ M Seager, D J Cullen, G Pearson, et al.Gastroenterology|March 7, 2001
Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin productionN J Wight, K Gottesdiener, N M Garlick, et al.The New England Journal of Medicine|May 30, 1996
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugsA S Taha, N Hudson, C J Hawkey, et al.Alimentary Pharmacology & Therapeutics|July 20, 2007
A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's diseaseJ C Mansfield, M Parkes, A B Hawthorne, et al.Alimentary Pharmacology & Therapeutics|August 11, 2005
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?L J Tata, P J Fortun, R B Hubbard, et al.Health Technology Assessment (Winchester, England)|August 22, 2025
Eradication of <i>Helicobacter pylori</i> for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCTC J Hawkey, Anthony J Avery, Carol Ac Coupland, et al.The New England Journal of Medicine|November 23, 2000
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study GroupC Bombardier, L Laine, A Reicin, et al.Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cellsR J Coffey, C J Hawkey, L Damstrup, et al.Alimentary Pharmacology & Therapeutics|October 18, 2005
Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinN D Yeomans, A I Lanas, N J Talley, et al.Pageof 24